Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Like I said, the inevitable shorting de-rampers will appear .....
Twice before in the last seven years DDDD has touched this level and then look at the chart to tell you what happened next. We are a FAR more developed company now. Current price is crazy but it will change for the better, of that I have no doubt.
Getting a bit silly now this price isn't it. Anyone who doesn't think that Merck or another big pharma won't be considering dropping a very small amount of money to them to pick up 4D and all of its pipeline and patents for next to nothing is nuts. Its a challenging hold currently but one whiff of a big pharma buy and this could be 100p in an instant. Best to switch off, ignore the inevitable shorting de-ramping, and await news.
£48m market cap now…. and 4D remain silent. Are they seriously asking for shareholders to vote for BoD pay increases!?!
Nobody needs a hug from 4D or hand holding but if potential investors don’t feel part of the company, don’t receive regular comms and lack confidence in the BoD then they are less likely to invest and less likely to support when asked to make these difficult decisions with their hard earned money. That’s entirely in 4D’s hands and they are failing on that front. Seemingly not seeing the link between keeping investors onside and asking them to stump up more money (potentially).
Great post.
I do think there has been massive overreaction here, fuelled by those that are profiting from a falling share price and the company themselves being poor in their approach to shareholders. It was discussed in the recent video that Duncan doesn’t have an online presence, doesn’t seem to care about it and I suspect why nobody is being held to account on that by him.
Oxford finance is highly likely. We know it is and we know Duncan is in talks.
Possible raise — yes, could happen, but my thoughts are that it genuinely is for opportunity and development use. Blautix phase 3 would be expensive and if a partner doesn’t step up with upfront money then 4D may need to fund it. There would no doubt be a significant SP spike on Phase 3 announcement to potentially take advantage of in terms of a raise. That’s probably the right business move to prepare for, even if the funds aren’t needed (due to collab with upfront payment).
Company announcing possible dilution has given the market all it needs to lower the price here, thereby reducing the value of a raise and frustrating shareholders in the process.
If money genuinely is tight then why not use some of the 40% dilution option they have access to already? They haven’t yet, which suggests that the situation is not desperate, and again, that Oxford finance or other funding is likely. My guess (hope!) is that Oxford funding or similar is announced before the AGM to ensure investors are onside as currently it will be a very angry room.
Since few other investors are buying at present, who was the person or entity that bought 2m of these shares on Wednesday? TR1 would be nice.
Simply my thoughts and opinions.
Yes, apparently I am three people. Absolute clown @Sang.
Yes, agree. This is where a leader earns the support and respect of his or her shareholders, if they are valued in any way. Silence is not really an option at this stage. Could always email investor relations ir@4dpharmaplc.com ....... though I am still waiting for my two previous emails (sent weeks ago) to be responded to.
Given where we are currently its not going to be too difficult a decision for a big Pharma, @Merck or another to pick us up on the cheap. I hope the BoD have a plan up their sleeve as its painful currently and they are wide open to being taken out. Current Market cap of 53m is pocket change. Won't be selling but certainly frustrating.
I don’t think buy/sell data is inaccurate at all. Watched the trades for much of the day (sad I know!). Majority were clearly buys from the price at the time. I have no doubt whatsoever that it was at least 2-1 buys to sells and the data supports that too.
The second it hit 30p, boom! Floods of buys pushed through. They had clearly decided that they wanted to get the price down there to allow that entry. When that buying is finished I’m sure they will release this to let their mates profit from their lovely low entry. No question that this is being manipulated currently. More than any other share I’ve seen.
Just from watching the trades going through today and the prices they went through at it seems fairly accurate to me. Lots and lots of buys. Extreme manipulation here and for a reason I’m sure. Eventually, perhaps sooner than we expect, all will be revealed.
Tweet has been removed. What did it say?
Its been held and driven down for days now with a clear intent to get it to 30p for these buys to load up. Dreadful that the market can be manipulated in this manner. Loading up is still happening it seems and then I suspect this will be released.
That's true and amazing news for cancer treatment if continued in larger scale trials/treatment. Fortunately, 4D is focused on multiple diseases, Parkinson's, Asthma, Alzheimer's, IBS, Cancer and more so they are not a one trick pony.
Coincidence? Employee share options RNS yesterday for shares to be added today, price very clearly intentionally driven down yesterday and this morning to break 30p. Sea of buys entered at 30p. Perhaps some news will be incoming that us simple PI's are not yet informed about. Not ramping, simply hopeful!
Expecting a TR1 after all of those buys were pushed through at 30p. May be been shorts departing but more likely someone looking for entry. Perhaps we do have an II interested after all.
Perhaps shorts have been assisted to make their exit...
Well, someone switched on the 'buy' button at 30p didn't they...